Sponsor:
Theratechnologies
Code:
NCT05388474
Conditions
HIV Infections
Multi-Antiviral Resistance
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
No ibalizumab or Pre-ibalizumab treatment
On ibalizumab treatment
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-19. This information was provided to ClinicalTrials.gov by Theratechnologies on 2025-02-07.